StockData
CME Group Inc. logo

CME Group Inc. (CME) operating KPIs

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/3021% above fair value
$303.14+6.72 (+2.27%)

Close on Oct 30, 2026Market cap $109.00BP/E 25.7Yield 1.65%

CME cME Group equity in net earnings of unconsolidated subsidiaries (primarily 27% of S&P Dow Jones Indices LLC) ($M)

CME Form 8-K / 10-Q / 10-K Income Statement & SEC XBRL

Latest, Q3 2026
103
Period ended Sep 30, 2026
Change on a year earlier
+6.7%
96.3 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
35
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCME Group equity in net earnings of unconsolidated subsidiaries (primarily 27% of S&P Dow Jones Indices LLC) ($M)Year on yearSource
Q3 2026Sep 30, 2026103+6.7%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2026-10-21 ↗
Q2 2026Jun 30, 202697.7-1.3%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2026-07-22 ↗
Q1 2026Mar 31, 2026102+16.1%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2026-04-22 ↗
Q4 2025Dec 31, 202588.2-3.3%CME Form 10-K (2026-02-26) ↗
Q3 2025Sep 30, 202596.3+11.8%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2026-10-21 ↗
Q2 2025Jun 30, 202599+14.6%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2026-07-22 ↗
Q1 2025Mar 31, 202588.2+1.1%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2026-04-22 ↗
Q4 2024Dec 31, 202491.2+36.5%CME Form 10-K (2026-02-26) ↗
Q3 2024Sep 30, 202486.1+12.1%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2025-10-22 ↗
Q2 2024Jun 30, 202486.4+15.0%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2025-07-23 ↗
Q1 2024Mar 31, 202487.2+11.5%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2025-04-23 ↗
Q4 2023Dec 31, 202366.8+4.4%CME Form 10-K (2026-02-26) ↗
Q3 2023Sep 30, 202376.8+0.4%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2024-10-23 ↗
Q2 2023Jun 30, 202375.1-14.0%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2024-07-24 ↗
Q1 2023Mar 31, 202378.2+6.7%CME Group Form 8-K Earnings Release (Item 2.02 EX-99.1), filed 2024-04-24 ↗
Q4 2022Dec 31, 202264-5.2%CME Form 10-K (2025-02-27) ↗

Cite this data

StockData. (2026). CME CME Group equity in net earnings of unconsolidated subsidiaries (primarily 27% of S&P Dow Jones Indices LLC) ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from CME SEC filings and investor materials. https://stockdatahq.com/stocks/cme/kpis/cme-equity-earnings

See every metric in the CME KPI table. Data updated Oct 28, 2026.